NCT05321121View on ClinicalTrials.gov

Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 12, 2021

Primary Completion Date

October 21, 2023

Study Completion Date

October 21, 2023

Conditions
Rib FracturesPain, Acute
Interventions
DRUG

Dexmedetomidine

Dexmedotomidine for Acute Pain Control in Patients with Multiple Rib Fractures

OTHER

Placebo

The control arm will receive an infusion of normal saline

Trial Locations (1)

92868

University of California, Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT05321121 - Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial | Biotech Hunter | Biotech Hunter